HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takahiro Osuga Selected Research

Lung Abscess

1/2022A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takahiro Osuga Research Topics

Disease

9Neoplasms (Cancer)
04/2022 - 01/2012
5Hepatocellular Carcinoma (Hepatoma)
04/2022 - 01/2016
5Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 08/2012
3Neoplasm Metastasis (Metastasis)
02/2021 - 07/2015
2Esophageal Neoplasms (Esophageal Cancer)
11/2018 - 10/2015
2Stomach Neoplasms (Stomach Cancer)
01/2016 - 08/2015
1Carcinogenesis
04/2022
1Non-alcoholic Fatty Liver Disease
04/2022
1Iron Overload
04/2022
1Cholangiocarcinoma
01/2022
1Lung Abscess
01/2022
1Liver Neoplasms (Liver Cancer)
01/2022
1Renal Cell Carcinoma (Grawitz Tumor)
02/2021
1Liposarcoma
01/2019
1Breast Neoplasms (Breast Cancer)
01/2019
1Sarcoma (Soft Tissue Sarcoma)
01/2019
1Esophageal Squamous Cell Carcinoma
11/2018
1Leukemia
06/2016
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2016
1Fanconi Syndrome (Syndrome, Fanconi)
07/2015
1Neutropenia
03/2015
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2012
1Adenocarcinoma
01/2012

Drug/Important Bio-Agent (IBA)

5Liposomes (Liposome)IBA
06/2016 - 01/2012
5FucoseIBA
06/2016 - 01/2012
4Pharmaceutical PreparationsIBA
01/2016 - 01/2012
4FucosyltransferasesIBA
01/2016 - 01/2012
3Docetaxel (Taxotere)FDA Link
11/2018 - 08/2015
3Cisplatin (Platino)FDA LinkGeneric
11/2018 - 01/2012
2gadolinium ethoxybenzyl DTPAFDA Link
04/2022 - 01/2022
2IronIBA
04/2022 - 11/2021
2Fluorouracil (Carac)FDA LinkGeneric
11/2018 - 10/2015
2nedaplatinIBA
11/2018 - 10/2015
2Bevacizumab (Avastin)FDA Link
07/2015 - 03/2015
1Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA
04/2022
1CateninsIBA
04/2022
18-Hydroxy-2'-DeoxyguanosineIBA
04/2022
1Ferritins (Ferritin)IBA
04/2022
1lenvatinibIBA
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1LigandsIBA
09/2021
1Immune Checkpoint InhibitorsIBA
09/2021
1eribulinFDA Link
01/2019
1Daunorubicin (Cerubidine)FDA LinkGeneric
06/2016
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2016
1Messenger RNA (mRNA)IBA
01/2016
1sialosyl-Tn antigenIBA
01/2016
1SialyltransferasesIBA
01/2016
1Small Interfering RNA (siRNA)IBA
01/2016
1Histone Deacetylase InhibitorsIBA
01/2016
1Trastuzumab (Herceptin)FDA Link
08/2015
1Zoledronic Acid (Zometa)FDA Link
07/2015
1DenosumabFDA Link
07/2015
1Capecitabine (Xeloda)FDA Link
03/2015
1Irinotecan (Camptosar)FDA LinkGeneric
03/2015
1Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2015
1Cetuximab (Erbitux)FDA Link
08/2012
1Tumor Biomarkers (Tumor Markers)IBA
01/2012
1EnzymesIBA
01/2012
1AntigensIBA
01/2012
1CY5.5 cyanine dyeIBA
01/2012

Therapy/Procedure

8Therapeutics
01/2022 - 01/2012
1Nephrectomy
02/2021
1Neoadjuvant Therapy
11/2018
1Drug Therapy (Chemotherapy)
07/2015